Commentary on Enns et al. (2016): Supervised injection facilities as a cost-effective intervention.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26860246.
- Also identified by DOI 10.1111/add.13242 and PMC identifier 5279864.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors build upon evidence for expanded access to supervised injection facilities (SIFs) based on a growing body of cost-effectiveness literature that evaluates estimable costs and costs avoided from infectious diseases. Future directions for economic evaluations of SIFs should seek to examine broader SIF benefits and costs that encompass increased access to addiction treatment and other key health and social outcomes.
Medical subject headings
- Needle-Exchange Programs
- Substance Abuse, Intravenous